Matches in SemOpenAlex for { <https://semopenalex.org/work/W2012433054> ?p ?o ?g. }
Showing items 1 to 93 of
93
with 100 items per page.
- W2012433054 endingPage "765" @default.
- W2012433054 startingPage "761" @default.
- W2012433054 abstract "Twenty-four evaluable patients with stage T4 breast cancer were entered into a phase II study and received chemotherapy comprising cyclophosphamide 1,000 mg m-2 i.v., doxorubicin 50 mg m-2 i.v., vincristine 1.4 mg m-2 i.v. and prednisolone 40 mg orally for 5 days, given 3 weekly for four cycles prior to undergoing loco-regional radiotherapy. All patients completed treatment as planned with no major acute toxicity from either chemotherapy or radiotherapy. Subsequently 52 patients with stage T4 breast cancer were randomised in a phase III trial to receive either radiotherapy alone (RT) or this chemotherapy and radiotherapy (CHOP + RT). A significantly higher complete response rate was achieved in the CHOP + RT treatment arm (P = 0.03). However a larger proportion of the RT arm achieved loco-regional control after salvage treatment for relapse such that 50% of the RT arm and 57% of the CHOP + RT arm had no evidence of loco-regional disease at the time of last follow-up or death. There was no statistical difference in time to distant relapse or overall survival. Analysis of the pilot study showed results comparable to the trial CHOP + RT arm. This trial suggests that this cytotoxic therapy used in conjunction with radiotherapy has only marginal value in improving prognosis in locally advanced breast cancer." @default.
- W2012433054 created "2016-06-24" @default.
- W2012433054 creator A5006199301 @default.
- W2012433054 creator A5023179046 @default.
- W2012433054 creator A5035102653 @default.
- W2012433054 creator A5041941275 @default.
- W2012433054 creator A5048471607 @default.
- W2012433054 creator A5049740473 @default.
- W2012433054 date "1992-05-01" @default.
- W2012433054 modified "2023-10-17" @default.
- W2012433054 title "Locally advanced breast cancer: report of phase II study and subsequent phase III trial" @default.
- W2012433054 cites W1505417176 @default.
- W2012433054 cites W1892756525 @default.
- W2012433054 cites W1899541887 @default.
- W2012433054 cites W1913192549 @default.
- W2012433054 cites W1966158468 @default.
- W2012433054 cites W1972832488 @default.
- W2012433054 cites W1995671931 @default.
- W2012433054 cites W2008686530 @default.
- W2012433054 cites W2019546222 @default.
- W2012433054 cites W2030892741 @default.
- W2012433054 cites W2039642936 @default.
- W2012433054 cites W2040896752 @default.
- W2012433054 cites W2041690603 @default.
- W2012433054 cites W2058681718 @default.
- W2012433054 cites W2086411676 @default.
- W2012433054 cites W2090542402 @default.
- W2012433054 cites W2403949082 @default.
- W2012433054 cites W2409673920 @default.
- W2012433054 cites W2413912677 @default.
- W2012433054 doi "https://doi.org/10.1038/bjc.1992.160" @default.
- W2012433054 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/1977400" @default.
- W2012433054 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/1586604" @default.
- W2012433054 hasPublicationYear "1992" @default.
- W2012433054 type Work @default.
- W2012433054 sameAs 2012433054 @default.
- W2012433054 citedByCount "17" @default.
- W2012433054 countsByYear W20124330542013 @default.
- W2012433054 countsByYear W20124330542016 @default.
- W2012433054 crossrefType "journal-article" @default.
- W2012433054 hasAuthorship W2012433054A5006199301 @default.
- W2012433054 hasAuthorship W2012433054A5023179046 @default.
- W2012433054 hasAuthorship W2012433054A5035102653 @default.
- W2012433054 hasAuthorship W2012433054A5041941275 @default.
- W2012433054 hasAuthorship W2012433054A5048471607 @default.
- W2012433054 hasAuthorship W2012433054A5049740473 @default.
- W2012433054 hasBestOaLocation W20124330542 @default.
- W2012433054 hasConcept C121608353 @default.
- W2012433054 hasConcept C126322002 @default.
- W2012433054 hasConcept C141071460 @default.
- W2012433054 hasConcept C143998085 @default.
- W2012433054 hasConcept C2776694085 @default.
- W2012433054 hasConcept C2776755627 @default.
- W2012433054 hasConcept C2779429289 @default.
- W2012433054 hasConcept C2779725641 @default.
- W2012433054 hasConcept C509974204 @default.
- W2012433054 hasConcept C530470458 @default.
- W2012433054 hasConcept C71924100 @default.
- W2012433054 hasConceptScore W2012433054C121608353 @default.
- W2012433054 hasConceptScore W2012433054C126322002 @default.
- W2012433054 hasConceptScore W2012433054C141071460 @default.
- W2012433054 hasConceptScore W2012433054C143998085 @default.
- W2012433054 hasConceptScore W2012433054C2776694085 @default.
- W2012433054 hasConceptScore W2012433054C2776755627 @default.
- W2012433054 hasConceptScore W2012433054C2779429289 @default.
- W2012433054 hasConceptScore W2012433054C2779725641 @default.
- W2012433054 hasConceptScore W2012433054C509974204 @default.
- W2012433054 hasConceptScore W2012433054C530470458 @default.
- W2012433054 hasConceptScore W2012433054C71924100 @default.
- W2012433054 hasIssue "5" @default.
- W2012433054 hasLocation W20124330541 @default.
- W2012433054 hasLocation W20124330542 @default.
- W2012433054 hasLocation W20124330543 @default.
- W2012433054 hasLocation W20124330544 @default.
- W2012433054 hasOpenAccess W2012433054 @default.
- W2012433054 hasPrimaryLocation W20124330541 @default.
- W2012433054 hasRelatedWork W1978070076 @default.
- W2012433054 hasRelatedWork W2036802760 @default.
- W2012433054 hasRelatedWork W2083438316 @default.
- W2012433054 hasRelatedWork W2111618869 @default.
- W2012433054 hasRelatedWork W2145349532 @default.
- W2012433054 hasRelatedWork W2330662417 @default.
- W2012433054 hasRelatedWork W2342164759 @default.
- W2012433054 hasRelatedWork W2387970634 @default.
- W2012433054 hasRelatedWork W2411938410 @default.
- W2012433054 hasRelatedWork W2418155614 @default.
- W2012433054 hasVolume "65" @default.
- W2012433054 isParatext "false" @default.
- W2012433054 isRetracted "false" @default.
- W2012433054 magId "2012433054" @default.
- W2012433054 workType "article" @default.